Immix Biopharma, Inc.
IMMXNasdaqCIK 1873835HealthcareFiscal year ends Dec 31
Reports and events: 68 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3017:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045143 |
| 2026-09-2907:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-044761 |
| 2026-08-0717:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036643 |
| 2026-07-2006:05 ET | 8-K | 8.01 Other events | 0001493152-26-033829 |
| 2026-05-2917:10 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-026431 |
| 2026-05-2117:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024872 |
| 2026-05-2106:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024707 |
| 2026-05-0717:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021764 |
| 2026-04-0616:37 ET | DEF 14A | Proxy statementPeriod 2026-04-06 | 0001493152-26-015320 |
| 2026-03-3017:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013663 |
| 2026-03-2717:28 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-013298 |
| 2026-03-2517:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-012721 |
| 2026-03-2517:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012714 |
| 2025-12-0817:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-026697 |
| 2025-12-0806:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026500 |
| 2025-11-2617:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025182 |
| 2025-11-0717:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021325 |
| 2025-09-0816:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-012804 |
| 2025-08-0817:28 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022829 |
| 2025-06-2317:01 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-016120 |
| 2025-06-0315:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-013417 |
| 2025-05-1917:23 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-03-31 | 0001641172-25-011519 |
| 2025-05-1917:19 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-011513 |
| 2025-05-0816:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009280 |
| 2025-04-3017:49 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0001641172-25-006711 |
| 2025-03-2518:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000387 |
| 2024-11-1216:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044787 |
| 2024-08-1217:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031358 |
| 2024-07-2609:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029174 |
| 2024-07-2221:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-028595 |
| 2024-06-1417:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023947 |
| 2024-05-2017:27 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020785 |
| 2024-05-0916:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018458 |
| 2024-04-2917:26 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001493152-24-017060 |
| 2024-03-2916:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011975 |
| 2024-02-0609:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-005043 |
| 2024-02-0516:37 ET | 8-K | 8.01 Other events | 0001493152-24-004933 |
| 2023-11-1320:24 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040182 |
| 2023-08-3016:15 ET | SC 13D | Ownership report, active investor | 0001068238-23-000182 |
| 2023-08-2216:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-029822 |
| 2023-08-1116:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027844 |
| 2023-07-1417:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-024626 |
| 2023-06-0806:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-020507 |
| 2023-05-1217:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016721 |
| 2023-04-2516:52 ET | DEF 14A | Proxy statementPeriod 2023-04-25 | 0001493152-23-013537 |
| 2023-03-2716:15 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-009091 |
| 2023-03-2208:42 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-008484 |
| 2023-03-1306:05 ET | 8-K/A | 7.01 Regulation FD disclosure | 0001493152-23-007317 |
| 2023-03-1321:48 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-23-007312 |
| 2023-01-1817:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-001795 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.